Livemedia Home
A+ | A-

 Login / Register to Livemedia



Υπενθύμιση κωδικού

11/09/2020 Congresses | 7th Official pre-ESH International Congress Satellite Symposium

Congresses | 7th Official pre-ESH International Congress Satellite Symposium  
 

Share

22.875 total
638 live
841 video
392 photo
Views:
Registration  
For your registration please click here.

PLEASE ENTER YOUR USERNAME AND PASSWORD TO ACCESS THE LIVE WEBCAST
You can login if you are a user. If you can't remember your password you can click 'Forgot your Password?' link.
Υπενθύμιση κωδικού

Watch live and on demand the 7h Official Pre ESH Congress Satellite Symposium, entitled ''Update on Difficult to Control Hypertension and Related comorbidities'' of European Society of Hypertension (ESH), which will take place on 11 – 12 September 2020, in Athens, in Benaki' s Museum.

For more information, please click here.

S. Sokolovic (BA) | The microcirculation... 22
M. Lopez-Sublet (FR) | The aortic stiffness 16
K. Dimitriadis (GR) | The MSNA 25
D. Lovic (RS) | Transcutaneous electro-stimulator... 03
A. Kollias (GR) | The ABPM 20
N.R. Robles (ES) | The Urinary albumin excretion... 11
I. Andrikou (GR) | Renal resistive index 11
M. Marketou (GR | The MicroRNA 11
E. Gkaliagkousi (GR) | Endothelial microvesicles 13
A. Pittaras (GR) | Cardiorespiratory fitness 08
C. Grassos (GR) | Global myocardial longitudinal... 08
Discussion with the audience 08
V. Kotsis (GR) | Accurate measurement of... 06
H. Triantafilidi (GR) | Should an asymptomatic... 13
J. Brguljan (SI) | A hypertensive, diabetic... 11
D. Farmakis (GR) | Does long term uncontrolled... 03
M. Kallistratos (GR) | What is the role of... 17
C. Chrysochoou (GR) | What is the role of... 19
A. Kokkinos(GR | What is the role of SGLT2... 31
V. Bistola (GR) | What is the role of diuretics? 17
A. Ziakas (GR) | What is the role of devices? 11
Θ. Μακρής | Ο ρόλος του σταθερού συνδυασμού... 09
F. Mallamaci (IT) | OSAS in CKD 05
C. Savopoulos (GR) | Vascular aging and stroke 06
A. Coca (ES) | How to prevent dementia 14
R. Kreutz (DE) | RAS blockers and COVID -19.... 18
D. Vlahakos (GR) | Opposing effects of RAS... 13
R. Kalaitzidis (GR) | Antineoplastic drugs... 18
Y. Sharabi (IL) |Treating hypertension in... 05
A. Protogerou (GR) | In adolescents with... 16
R. Cifkova (CZ) | In pregnant woman during... 12
P. Sarafidis (GR) | In patients on dialysis 17
A. Benetos (GR) | In very elderly frail patients 21
A. Persu (BE) | When and how to screen for... 17
G. Kaltsas (GR) | Excluding primary aldo... 08
M. Peppa (GR) | Thyroid disorders and Hypertension 14
F. Luft (DE) | When and how to screen for... 09
G. Mancia (IT) | Which BP should be used 21
E. Agabiti-Rosei (IT) | The treatment of... 04
J. Redon (ES) | The treatment of hypertension... 05
A. Manolis (GR) | The treatment of hypertension... 11
C. Thomopoulos (GR) | The position of beta... 06
K. Narkiewicz (PL) | The SPC strategy at... 02
G. Parati (IT) | The management of white... 06
G. Stergiou (GR) | The management of masked... 14
Α. Πιτταράς | Γεφυρώνοντας το Καρδιαγγειακό... 03
D. Gaita (RO) | Daily exercise is crucial 03
C. Borghi (IT) | Managing high uric acid... 04
P. Van de Borne (BE) | Addition of spironolactone/clonidine... 14
J. Vaclavik (CZ) | Managing the non-adherent... 11
D. Kandzari (US) |Evidence of radiofrequency... 17
M. Azizi (FR) | Evidence of ultrasound RDN... 21
G. Grassi (IT) | Effects beyond BP reduction 23
F. Mahfoud (DE) | Procedural Success Marker 18
Discussion with the audience 15
T. Weber (AT) | Identification of BP responders... 19
A. Pathak (FR) | Patient preference/non-adherence 13
A. Januszewicz (PL) | Patient with Resistant... 16
V. Papademetriou (US) | Patient with isolated... 13
R.E. Schmieder (DE) | Should Guidelines recommendations... 10
Discussion with the audience 07
J.A. Garcia Donaire (ES) | The nephrological... 11
J. Davies (UK) | The interventionalist’s... 09
M. Doumas (GR) | The hypertensiologist’s... 15
Discussion with the audience 08
C. Fragoulis (GR), | The Greek experience 10
R. Boulestreau (FR) | The French experience 01
M. Salvetti (IT) | The Italian experience 01
A. Triantafyllou (GR) | Preliminary data 03
G. Parati (IT) | Current status 05
D. Konstantinidis (GR) | The Greek experience 01
T. Weber (AT) | 4th ESH Research project:... 04
J. Vaclavik (CZ) | Renal artery stenting... 03
END OF SYMPOSIUM - CLOSING REMARKS 08